Stroke Risk Stratification: CHA2DS2-VA or CHA2DS2-VASc? - 30/03/19
Doi : 10.1016/j.hlc.2018.09.013
David Brieger, MBBS PhD FCSANZ a, b, ⁎ 
a Department of Cardiology, Concord Hospital, Sydney, Australia
b University of Sydney, Sydney, Australia
⁎Corresponding author at: Department of Cardiology, Concord Hospital, Sydney, Australia.Department of CardiologyConcord HospitalSydneyAustralia
Cia Connell, BPharm GCPharmPrac MClinPharm
The National Heart Foundation of Australia, Melbourne, Australia
Ben Freedman, MBBS PhD FRACP a, b
a Sydney Medical School, The University of Sydney, Sydney, Australia
b Heart Research Institute, Charles Perkins Centre, University of Sydney, Sydney, Australia
Il testo completo di questo articolo è disponibile in PDF.
© 2018
Pubblicato da Elsevier Masson SAS.
Vol 28 - N° 5
P. e103 - maggio 2019 Ritorno al numero
Articolo precedente
- The Marathon of Life: From Near-Death by Avalanche to Ultra-Trail Run
- Sylweriusz Kosi?ski, Pawe? Podsiad?o, ?ukasz Migiel, Robert Ga??zkowski, Rafa? Drwi?a, Tomasz Darocha
- Haptoglobin Genotype as a Prognostic Factor for Adverse Events in Coronary Artery Bypass Surgery in Diabetic Patients
- Yaron D. Barac, Uzi Milman, Efrat Kurtzwald Josefson, Fabian Emrich, Idit Lavi, Victor Rubchevsky, Friedrich-Wilhelm Mohr, Donald D. Glower, Dan Aravot, Chen Shapira
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?